<SEC-DOCUMENT>0001213900-25-005989.txt : 20250123
<SEC-HEADER>0001213900-25-005989.hdr.sgml : 20250123
<ACCEPTANCE-DATETIME>20250123163007
ACCESSION NUMBER:		0001213900-25-005989
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250116
FILED AS OF DATE:		20250123
DATE AS OF CHANGE:		20250123

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bent Bruce
		CENTRAL INDEX KEY:			0001746671
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41422
		FILM NUMBER:		25550518

	MAIL ADDRESS:	
		STREET 1:		750 BONHAM PARKWAY
		CITY:			LANTANA
		STATE:			TX
		ZIP:			76226

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HeartSciences Inc.
		CENTRAL INDEX KEY:			0001468492
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				261344466
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			0430

	BUSINESS ADDRESS:	
		STREET 1:		550 RESERVE ST, SUITE 360
		CITY:			SOUTHLAKE
		STATE:			TX
		ZIP:			76092
		BUSINESS PHONE:		682-237-7781

	MAIL ADDRESS:	
		STREET 1:		550 RESERVE ST, SUITE 360
		CITY:			SOUTHLAKE
		STATE:			TX
		ZIP:			76092

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Heart Test Laboratories, Inc.
		DATE OF NAME CHANGE:	20090716
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-01-16</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001468492</issuerCik>
        <issuerName>HeartSciences Inc.</issuerName>
        <issuerTradingSymbol>HSCS</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001746671</rptOwnerCik>
            <rptOwnerName>Bent Bruce</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O HEARTSCIENCES INC.,</rptOwnerStreet1>
            <rptOwnerStreet2>550 RESERVE STREET, SUITE 360</rptOwnerStreet2>
            <rptOwnerCity>SOUTHLAKE</rptOwnerCity>
            <rptOwnerState>TX</rptOwnerState>
            <rptOwnerZipCode>76092</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Employee Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.33</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2025-01-16</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>6000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2035-01-16</value>
                <footnoteId id="F3"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>6000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>6000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These options were granted to the Reporting Person effective as of January 16, 2025 (the &quot;Effective Date&quot;), pursuant to the approval of the compensation committee of the Issuer's board of directors.</footnote>
        <footnote id="F2">The options shall vest and be exercisable as follows: one-fourth of the options vested on the Effective Date and the remainder of the options shall vest in equal increments thereafter on each successive three-month anniversary of the Effective Date, subject to the Reporting Person's continued service on the Board through each applicable vesting date and subject to the terms of the Issuer's 2023 Equity Incentive Plan (the &quot;2023 Plan&quot;).</footnote>
        <footnote id="F3">These options expire ten years from the Effective Date, unless terminated sooner in accordance with the Issuer's 2023 Plan or the underlying options grant agreement.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Andrew Simpson, Attorney-in-fact</signatureName>
        <signatureDate>2025-01-23</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
